N-HALOGENATED AMINO ACID FORMULATIONS

摘要

The present invention relates to a method for treating a tissue infection comprising contacting the infected tissue with a pharmaceutically effective amount of a formulation comprising a N-halogenated amino acid and a phase t ransfer agent. This specification also describes a formulation having antimi crobial activity comprising a N-halogenated amino acid and a phase transfer agent.